Skip to content
Menu

Apotex Health Corp. APTX.TO

Full chart Compare
Set alert

Price alert · APTX.TO

All alert types
39.44 CAD +0.98 (+2.55%)

As ofNov 13, 2026, 4:00 PM EST

38.50 Day range 40.10
26.05 52-week range 40.18
YTD
+46.07%
1 year
+46.07%
Market cap
9.03B
Revenue (ttm)
3.20B
Profit margin
-0.85%
EPS (ttm)
-0.14
Shares out
228.50M
Forward P/E
16.68
Dividend
0.06 (0.16%)
Ex-dividend date
Sep 15, 2026
YTD return
+46.07%
1-year return
+46.07%
Volume
506.15K
Avg volume
460.28K
Open
38.50
Previous close
38.46
Day's range
38.50 – 40.10
52-week range
26.05 – 40.18

5D +4.65 (+13.37%)

363840MonTueWedThuFri39.44

Key statistics

Enterprise value
11.55B
PEG ratio
0.00
Price / sales
2.82
Price / book
25.73
Dividend yield
0.16%
Payout ratio
0.00%
Revenue growth
-25.80%
Free cash flow
0
Total cash
258.76M
Total debt
3.02B
Return on equity
0.00%
Short % of float
0.00%
50-day average
33.04
200-day average
33.69

About Apotex Health Corp.

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. Apotex Health Corp. has a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. The company was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
Website
apotex.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on APTX.TO — it syncs with the Stock Master app.

Insider holders

APTX.TO insider holders
InsiderRelationLatest transactionDateShares held
Alon (Ariel Gershon)Senior Officer of IssuerOpening Balance-Initial SEDI ReportJun 8, 202648,622
Fishman (Barry)Senior Officer of IssuerOpening Balance-Initial SEDI ReportJun 8, 202666,721
Krinsky (Itzhak)Director of IssuerOpening Balance-Initial SEDI ReportJun 8, 202633,360
Krishnan (Kiran)Senior Officer of IssuerOpening Balance-Initial SEDI ReportJun 8, 202672,933
Mcclelland (Brian George)Senior Officer of IssuerOpening Balance-Initial SEDI ReportJun 8, 202632,414
Oberman (Allan)Director of IssuerExercise of rightsSep 17, 2026532,062

Fund ownership

APTX.TO fund ownership
Holder% heldSharesValueReported
Fidelity Investment Trust-Fidelity Series Canada Fund0.91%2,089,79282.42MSep 29, 2026
Fidelity Securities Fund-Fidelity Blue Chip Growth Fund0.77%1,772,10069.89MSep 29, 2026
Fidelity Investment Trust-Fidelity Diversified International Fund0.42%960,60037.89MSep 29, 2026
Fidelity Investment TRT-Fidelity SAI Intl SMA Completion Fd.0.38%865,90034.15MSep 29, 2026
Fidelity Securities Fund-Fidelity Blue Chip Growth K6 Fund0.16%374,30014.76MSep 29, 2026
Fidelity Investment Trust-Fidelity Diversified International K6 Fund0.15%334,01013.17MSep 29, 2026